AMGN vs BIIB
Amgen Inc. and Biogen Inc., side by side — 10 fiscal years reported in USD, drawn from SEC filings.
Most recent reported year
| Metric | AMGN | BIIB |
|---|---|---|
| Revenue | $36.8B | $9.9B |
| Net income | $7.7B | $1.3B |
| Gross margin | 67.2% | 75.7% |
| Net margin | 21.0% | 13.1% |
| Return on equity | 106.1% | 7.4% |
| Diluted EPS | $14.23 | $8.79 |
| Dividend / share | $9.66 | · |
| Payout ratio | 66.5% | · |
| Free cash flow | $8.1B | $2.1B |
| Equity | $8.7B | · |
| Net debt / equity | 5.25× | 0.18× |
| Current ratio | 1.14× | 2.68× |
| Revenue CAGR 5y | 7.6% | −6.0% |
| Profit CAGR 5y | 1.2% | −20.2% |
AMGN bills 3.7× the revenue of BIIB, and keeps more of each dollar of revenue as profit (21.0% against 13.1%).
The stronger figure of the pair is set in bold. That is arithmetic, not a recommendation — this page does not pick a winner. "·" marks a figure not available in our data.
10 years side by side
| Fiscal year | AMGN | BIIB |
|---|---|---|
| FY2025 | $36.8B | $9.9B |
| FY2024 | $33.4B | $9.7B |
| FY2023 | $28.2B | $9.8B |
| FY2022 | $26.3B | $10.2B |
| FY2021 | $26.0B | $11.0B |
| FY2020 | $25.4B | $13.4B |
| FY2019 | $23.4B | $14.4B |
| FY2018 | $23.7B | $13.5B |
| FY2017 | $22.8B | $12.3B |
| FY2016 | $23.0B | $11.4B |
Bottom line
| Fiscal year | AMGN | BIIB |
|---|---|---|
| FY2025 | $7.7B | $1.3B |
| FY2024 | $4.1B | $1.6B |
| FY2023 | $6.7B | $1.2B |
| FY2022 | $6.6B | $3.0B |
| FY2021 | $5.9B | $1.6B |
| FY2020 | $7.3B | $4.0B |
| FY2019 | $7.8B | $5.9B |
| FY2018 | $8.4B | $4.4B |
| FY2017 | $2.0B | $2.5B |
| FY2016 | $7.7B | $3.7B |
19 fiscal years
| Fiscal year | Difference | Ahead |
|---|---|---|
| FY2025 | +$26,860,400,000 | AMGN |
| FY2024 | +$23,748,100,000 | AMGN |
| FY2023 | +$18,354,400,000 | AMGN |
| FY2022 | +$16,149,600,000 | AMGN |
| FY2021 | +$14,997,300,000 | AMGN |
| FY2020 | +$11,979,400,000 | AMGN |
| FY2019 | +$8,984,100,000 | AMGN |
| FY2018 | +$10,294,100,000 | AMGN |
| FY2017 | +$10,575,100,000 | AMGN |
| FY2016 | +$11,542,200,000 | AMGN |
| FY2015 | +$10,898,200,000 | AMGN |
| FY2014 | +$10,359,700,000 | AMGN |
| FY2013 | +$11,743,800,000 | AMGN |
| FY2012 | +$11,748,539,000 | AMGN |
| FY2011 | +$10,533,366,000 | AMGN |
| FY2010 | +$10,336,577,000 | AMGN |
| FY2009 | +$10,264,652,000 | AMGN |
| FY2008 | +$10,905,493,000 | AMGN |
| FY2007 | +$11,599,383,000 | AMGN |
AMGN has reported the higher revenue in every one of these 19 fiscal years. The gap has widened since the earliest year compared.
19 of 19 comparable fiscal years — a year missing data on either side is not counted.
19 fiscal years
| Fiscal year | Difference | Ahead |
|---|---|---|
| FY2025 | +7.9 pp | AMGN |
| FY2024 | −4.6 pp | BIIB |
| FY2023 | +12.0 pp | AMGN |
| FY2022 | −4.2 pp | BIIB |
| FY2021 | +7.0 pp | AMGN |
| FY2020 | −1.6 pp | BIIB |
| FY2019 | −7.4 pp | BIIB |
| FY2018 | +2.1 pp | AMGN |
| FY2017 | −13.1 pp | BIIB |
| FY2016 | +1.3 pp | AMGN |
| FY2015 | −1.3 pp | BIIB |
| FY2014 | −4.6 pp | BIIB |
| FY2013 | +0.3 pp | AMGN |
| FY2012 | +0.1 pp | AMGN |
| FY2011 | −1.5 pp | BIIB |
| FY2010 | +11.7 pp | AMGN |
| FY2009 | +9.1 pp | AMGN |
| FY2008 | +7.7 pp | AMGN |
| FY2007 | +2.6 pp | AMGN |
The higher net margin has changed hands between AMGN and BIIB over this period.
19 of 19 comparable fiscal years — a year missing data on either side is not counted.
Standard deviation, each side
BIIB's net margin has been more volatile than AMGN's over the 19 comparable fiscal years — 7.7 percentage points of standard deviation against 6.7.
19 of 19 comparable fiscal years — a year missing data on either side is not counted.
Year by year
The lead in net margin changed hands between AMGN and BIIB over these 19 fiscal years — AMGN led in 11 and BIIB in 8.
19 of 19 comparable fiscal years — a year missing data on either side is not counted.
Standard deviation, each side
AMGN's return on equity has been more volatile than BIIB's over the 19 comparable fiscal years — 38.6 percentage points of standard deviation against 10.4.
19 of 19 comparable fiscal years — a year missing data on either side is not counted.
Year by year
The lead in return on equity changed hands between AMGN and BIIB over these 19 fiscal years — AMGN led in 14 and BIIB in 5.
19 of 19 comparable fiscal years — a year missing data on either side is not counted.